Smalls Sliders opening new Louisiana can
Smalls Sliders is set to open in Bossier City on March 3. According to a press release, the latest Louisiana Can opening from the industry-disrupting cheeseburger slider concept is situated at 111 Armstrong Place, Bossier City, LA, right next to the Rocket Fast Car Wash on Benton Road.
Officials say to further celebrate the opening, the first 100 guests at the Bossier City Can will receive a pair of Smorange™ slides.
Catholic Charities of N La. to host Highland Parade lunch stop, open house
'Smalls Sliders is a staple here in Louisiana, and I'm thrilled to have the opportunity to continue introducing the concept to more guests,' said Chris McJunkins, local franchisee and operator of the Bossier City Can. 'Bossier City is a vibrant area with a unique and lively atmosphere that's perfect for Smalls Sliders. We can't wait to become a part of our Frequent Sliders' everyday lives here in Bossier City—whether it's for a casual bite on our patio or a celebration with loved ones, our Can is a place for good memories to be made.'
Officials say with five more Cans slated to drop and open over the next year, the Bossier City Can marks the 16th Smalls Sliders Can open in the state. Native to the Shreveport area, McJunkins currently owns and operates the West Monroe, Alexandria, and Shreveport Cans, in addition to developing Cans in Arkansas as well.
For more information on Smalls Sliders, slide thru to the website or visit the franchising website to learn more about opportunities.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ligand to Participate in September Investor Conferences
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor conferences: Citi 20th Annual BioPharma Conference (Boston): Management will participate in a fireside chat on September 3, 2025 at 11:15 a.m. ET. H.C. Wainwright 27th Annual Global Investment Conference (New York): Management will present on September 9, 2025 at 1:00 p.m. ET. Ligand management is scheduled to host one-on-one meetings with investors and attendees during these conferences. Investors interested in arranging one-on-one meetings should contact their Citi or H.C. Wainwright representative. About Ligand PharmaceuticalsLigand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner. Our business model is based on funding programs in mid- to late-stage drug development in return for economic rights, purchasing royalty rights in development stage or commercial biopharmaceutical products and licensing our technology to help partners discover and develop medicines. We partner with other pharmaceutical companies to attempt to leverage what they do best (late-stage development, regulatory management and commercialization) in order to generate our revenue. We operate two infrastructure-light royalty generating technology IP platform technologies. Our Captisol® platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our NITRICIL™ platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a broad range of indications. We have established multiple alliances, licenses and other business relationships with the world's leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter International. For more information, please visit Follow Ligand on X and LinkedIn. We use our investor relations website and X as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Investors should monitor our website and our X account, in addition to following our press releases, SEC filings, public conference calls and webcasts. Contacts Investors:Melanie Hermaninvestors@ 550-7761 Media:Kellie Walshmedia@ 315-6072Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain
TREVIGLIO, Italy & BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. ('Anaergia', the 'Company', 'us', or 'our') (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has signed a Binding Agreement ('Agreement') with a leading Spanish company specializing in renewable gas infrastructure projects. Under the terms of the Agreement, Anaergia will provide a range of services as well as its cutting-edge technology and equipment for over 15 new biomethane production plants across Spain. Anaergia will be responsible for the supply and construction of concrete tanks with Triton™ digesters, a proprietary technology featuring a patented configuration that significantly enhances process efficiency. In addition, the company will supply advanced mixing systems, also part of its proprietary technology, along with other critical components to facilitate the seamless operations of the plants. Anaergia is to commence activities on the first project this month, with all the projects in the development plan expected to be fully operational and integrated into Spain's gas pipeline network within forty-eight months. Anaergia anticipates total revenue of C$184 million from this Agreement, making it the Company's largest capital sale to date. 'This agreement marks a significant milestone in advancing Spain's renewable energy sector, fostering economic growth and environmental sustainability. The scale of this historic Agreement for Anaergia highlights the advantages of our strategic focus on leveraging proprietary technologies for the benefit of our customers, and underscores our growing presence and activities in Europe,' said Assaf Onn, CEO of Anaergia. 'We are most excited about this opportunity to demonstrate the value of our innovative solutions and to support the global transition to renewable energy.' About Anaergia Anaergia is a pioneering technology company in the renewable natural gas (RNG) sector, with over 250 patents dedicated to converting organic waste into sustainable solutions such as RNG, fertilizer, and water. We are committed to addressing a significant source of greenhouse gases (GHGs) through cost-effective processes. Our proprietary technologies, combined with our engineering expertise and vast experience in facility design, construction, and operation, position Anaergia as a leader in the RNG industry. With a proven track record of delivering hundreds of innovative projects over the past decade, we are well-equipped to tackle today's critical resource recovery challenges through diverse project delivery methods. As one of the few companies worldwide offering an integrated portfolio of end-to-end solutions, we effectively combine solid waste processing, wastewater treatment, organics recovery, high-efficiency anaerobic digestion, and biomethane production. Additionally, we operate RNG facilities owned by both third parties and Anaergia. This comprehensive approach not only reduces environmental impact but also significantly lowers costs associated with waste and wastewater treatment while mitigating GHG emissions. For further information please see: Forward-Looking Statements This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects Anaergia's current expectations regarding future events, including but not limited to, counterparty contractual performance, the capability of the Company's technology and performance with respect to the project objectives. Forward-looking information is based on a number of assumptions, including, but not limited to counterparty contractual performance, the full development, timing and funding of construction of the sixteen facilities, the capability of the Company's technology and performance with respect to the project objectives, the expected revenue from the agreement, and the sufficient sourcing of food waste and power generation. The Company is subject to a number of risks and uncertainties, many of which are beyond the Company's control. Such risks and uncertainties include, but are not limited to, the factors discussed under 'Risk Factors' in the Company's annual information form for the fiscal year ended December 31, 2024, and under 'Risks and Uncertainties' in the Company's most recent management's discussion and analysis. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws. Additional information on these and other factors that could affect Anaergia's operations or financial results are included in Anaergia's reports on file with Canadian regulatory authorities.
Business Wire
an hour ago
- Business Wire
AerSale ® Appoints Paul Hechenberger as Senior Vice President, General Counsel & Corporate Secretary
MIAMI--(BUSINESS WIRE)--AerSale® (NASDAQ: ASLE), a leading provider of aviation products and services, today announced the appointment of Paul Hechenberger as Senior Vice President, General Counsel & Corporate Secretary. Hechenberger brings more than four decades of legal, leadership, and aerospace experience to AerSale, with extensive expertise in complex commercial transactions, mergers and acquisitions, corporate governance, and compliance. Prior to joining AerSale, Hechenberger was a Partner with Miami-based law firm Shutts & Bowen. His previous leadership roles include serving as General Counsel at iAero Group, Deputy General Counsel at Spirit AeroSystems, General Counsel at BBA Aviation (Aftermarket Services), Chief M&A Counsel at BBA Aviation, and Corporate Counsel at Tyco Fire & Security. A U.S. Navy veteran, Hechenberger served as an EA-6B Naval Flight Officer, retiring with the rank of Captain after a combined 30 years of active and reserve service. He holds a Juris Doctor from the University of Florida, an MBA from the University of West Florida, and a BSBA from Villanova University. He is licensed to practice law in the state of Florida. "Paul's extensive legal expertise and deep understanding of the aerospace industry make him an outstanding addition to our executive team," said Nicolas Finazzo, Chief Executive Officer of AerSale. "His proven leadership and strategic counsel will be instrumental as we continue to grow our business and deliver value to our shareholders." About AerSale® AerSale serves airlines operating large jets manufactured by Boeing and Airbus and is dedicated to providing integrated aftermarket services and products designed to help aircraft owners and operators realize significant savings in the operation, maintenance and monetization of their aircraft, engines, and components. AerSale's offerings include Aircraft & Component MRO, Aircraft and Engine Sales and Leasing, Used Serviceable Material sales, and internally developed 'Engineered Solutions' to comply with regulatory mandates and/or to enhance aircraft performance and operating economics (e.g. AerSafe®, AerTrak®, and AerAware™).
